Prophylactic mastectomy and occult malignancy: Surgical and imaging considerations
Open Access
- 7 September 2022
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 127 (1) , 18-27
Abstract
Background: Sentinel node biopsy (SLNB) is not routinely recommended for patients undergoing prophylactic mastectomy (PM), yet omission remains a subject of debate among surgeons. A modern patient cohort was examined to determine occult malignancy (OM) incidence within PM specimens to reinforce current recommendations.Methods: All PM performed over a 5‐year period were retrospectively identified, including women with unilateral breast cancer who underwent synchronous or delayed contralateral PM or women with elevated cancer risk who underwent bilateral PM.Results: The study population included 772 patients (598 CPM, 174 BPM) with a total of 39 OM identified: 17 invasive cancers (14 CPM, 3 BPM) and 22 DCIS (19 CPM, 3 BPM). Of the 86 patients for whom SLNB was selectively performed, 1 micrometastasis was identified. In the CPM cohort, risk of OM increased with age, presence of LCIS of either breast, or presence of a non‐BRCA high‐penetrance gene mutation, while preoperative magnetic resonance imaging was associated with lower likelihood of OM.Conclusions: Given the low incidence of invasive OM in this updated series, routine SLNB is of low value for patients undergoing PM. For patients with indeterminate radiographic findings, discordant preoperative biopsies, LCIS, or non‐BRCA high‐penetrance gene mutations, selective SLNB implementation could be considered.Keywords
This publication has 40 references indexed in Scilit:
- Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissectionJournal of Surgical Oncology, 2010
- Indications for Sentinel Lymph Node Biopsy in the Setting of Prophylactic MastectomyJournal of the American College of Surgeons, 2009
- Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective MeasurementsJournal of Clinical Oncology, 2008
- Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?Cancer, 2008
- Detecting Occult Malignancy in Prophylactic Mastectomy: Preoperative MRI Versus Sentinel Lymph Node BiopsyAnnals of Surgical Oncology, 2007
- Selective use of sentinel lymph node surgery during prophylactic mastectomyCancer, 2006
- Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC TrialJNCI: Journal of the National Cancer Institute, 2006
- Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group TrialAnnals of Surgical Oncology, 2006
- Cytokeratin‐positive cells in sentinel lymph nodes in breast cancer are not random eventsCancer, 2004
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974